These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 22896025

  • 1. Survival, causes of death, and prognostic factors in systemic sclerosis: analysis of 947 Brazilian patients.
    Sampaio-Barros PD, Bortoluzzo AB, Marangoni RG, Rocha LF, Del Rio AP, Samara AM, Yoshinari NH, Marques-Neto JF.
    J Rheumatol; 2012 Oct; 39(10):1971-8. PubMed ID: 22896025
    [Abstract] [Full Text] [Related]

  • 2. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
    Joven BE, Almodovar R, Carmona L, Carreira PE.
    Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
    [Abstract] [Full Text] [Related]

  • 3. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P.
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [Abstract] [Full Text] [Related]

  • 4. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF, Pope JE, Ouimet JM.
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [Abstract] [Full Text] [Related]

  • 5. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
    Hashimoto A, Tejima S, Tono T, Suzuki M, Tanaka S, Matsui T, Tohma S, Endo H, Hirohata S.
    J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
    [Abstract] [Full Text] [Related]

  • 6. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
    Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA.
    Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
    [Abstract] [Full Text] [Related]

  • 7. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Muangchan C, Harding S, Khimdas S, Bonner A, Canadian Scleroderma Research group, Baron M, Pope J.
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.
    Foocharoen C, Nanagara R, Kiatchoosakun S, Suwannaroj S, Mahakkanukrauh A.
    Int J Rheum Dis; 2011 Aug; 14(3):282-9. PubMed ID: 21816025
    [Abstract] [Full Text] [Related]

  • 9. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.
    Hoffmann-Vold AM, Molberg Ø, Midtvedt Ø, Garen T, Gran JT.
    J Rheumatol; 2013 Jul; 40(7):1127-33. PubMed ID: 23637316
    [Abstract] [Full Text] [Related]

  • 10. Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis.
    Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R.
    J Med Assoc Thai; 2002 Nov; 85(11):1204-9. PubMed ID: 12546318
    [Abstract] [Full Text] [Related]

  • 11. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A, Bartosik I, Wuttge DM, Hesselstrand R.
    Scand J Rheumatol; 2009 Nov; 38(4):295-8. PubMed ID: 19214870
    [Abstract] [Full Text] [Related]

  • 12. Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.
    Jung M, Bonner A, Hudson M, Baron M, Pope JE, Canadian Scleroderma Research Group (CSRG).
    Scand J Rheumatol; 2014 Nov; 43(3):217-20. PubMed ID: 24650305
    [Abstract] [Full Text] [Related]

  • 13. Changes in causes of death in systemic sclerosis, 1972-2002.
    Steen VD, Medsger TA.
    Ann Rheum Dis; 2007 Jul; 66(7):940-4. PubMed ID: 17329309
    [Abstract] [Full Text] [Related]

  • 14. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
    Hasegawa M, Asano Y, Endo H, Fujimoto M, Goto D, Ihn H, Inoue K, Ishikawa O, Kawaguchi Y, Kuwana M, Muro Y, Ogawa F, Sasaki T, Takahashi H, Tanaka S, Takehara K, Sato S.
    Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
    [Abstract] [Full Text] [Related]

  • 15. Is vasculopathy associated with systemic sclerosis more severe in men?
    Panopoulos ST, Bournia VK, Sfikakis PP.
    J Rheumatol; 2013 Jan; 40(1):46-51. PubMed ID: 23118107
    [Abstract] [Full Text] [Related]

  • 16. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres.
    Fransen J, Popa-Diaconu D, Hesselstrand R, Carreira P, Valentini G, Beretta L, Airo P, Inanc M, Ullman S, Balbir-Gurman A, Sierakowski S, Allanore Y, Czirjak L, Riccieri V, Giacomelli R, Gabrielli A, Riemekasten G, Matucci-Cerinic M, Farge D, Hunzelmann N, Van den Hoogen FH, Vonk MC.
    Ann Rheum Dis; 2011 Oct; 70(10):1788-92. PubMed ID: 21784727
    [Abstract] [Full Text] [Related]

  • 17. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA.
    Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
    [Abstract] [Full Text] [Related]

  • 18. Survival and causes of death in 366 Hungarian patients with systemic sclerosis.
    Czirják L, Kumánovics G, Varjú C, Nagy Z, Pákozdi A, Szekanecz Z, Szucs G.
    Ann Rheum Dis; 2008 Jan; 67(1):59-63. PubMed ID: 17519276
    [Abstract] [Full Text] [Related]

  • 19. [Causes of death of patients with systemic sclerosis].
    Chwieśko S, Sierakowski S, Kowal-Bielecka O.
    Pol Merkur Lekarski; 2006 Oct; 21(124):341-4. PubMed ID: 17205772
    [Abstract] [Full Text] [Related]

  • 20. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ, Weisman MH, Seibold JR, Furst DE, Wong WK, Hurwitz EL, Mayes M, White B, Wigley F, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Clements PJ.
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.